Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 19, Issue 12, 2004, Pages 3054-3061

  Roccatello, Dario ^a,b   Baldovino, Simone ^a,b   Rossi, Daniela ^a,b   Mansouri, Morteza ^a,b   Naretto, Carla ^a,b   Gennaro, Mariella ^a,b   Cavallo, Roberto ^a   Alpa, Mirella ^a   Costanzo, Piera ^a   Giachino, Osvaldo ^a   Mazzucco, Gianna ^b   Sena, Luigi Massimino ^a,b  

^a S GIOVANNI BOSCO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti CD20 monoclonal antibody; Glomerulonephritis; Rituximab; Type II mixed cryoglobulinaemia

Indexed keywords

CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INSULIN; INTERFERON; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; CRYOGLOBULINEMIA; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GENOTYPE; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LEUKOPENIA; MALE; MUSCLE WEAKNESS; PARESTHESIA; PRIORITY JOURNAL; PROTEINURIA; PURPURA; SIDE EFFECT; SKIN ULCER; SYSTEMIC VASCULITIS; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; BLOOD SEDIMENTATION; BONE MARROW; CRYOGLOBULINEMIA; FEMALE; GLOMERULONEPHRITIS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 19944429904     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh469     Document Type: Article

References (20)

1. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia: a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 140: 837-856
2. Tarantino A, Campise M, Banfi G et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-623
3. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, Font J. Mixed cryoglobulinemia: new concepts. Lupus 2000; 9: 83-91
4. Fornasieri A, Li M, Armelloni S et al. Glomerulonephritis induced by human IgMκ-IgG cryoglobulins in mice. Lab Invest 1993; 69: 531-540
5. Roccatello D, Morsica G, Picciotto G et al. Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C virus (HCV) infection. Clin Exp Immunol 1997; 110: 9-14
6. Roccatello D, Isidoro C, Mazzucco G et al. Role of monocytes in cryoglobulinemia-associated nephritis. Kidney Int 1993; 43: 1150-1155
7. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-941
8. Zignego AL, Giannelli F, Marrocchi ME et al. T[14;18] translocation in chronic hepatitis C virus infection. Hepatology 2000; 31: 474-479
9. Shan D, Ledbetter JA, Press OW. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 1998; 91: 1644-1652
10. Byrd JC, White CA, Link B et al. Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity. Ann Oncol 1999; 10: 1525-1527
11. Saleh MN, Gutheil J, Moore M et al. A pilot study of the anti-CD20 monoclonal antibody Rituximab in patients with refractory immune thrombocytopenia. Semin Oncol 2000; 27: 99-103
12. Zecca M, De Stefano P, Nobili B, Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood 2001; 97: 3995-3997
13. Zaja F, De Vita S, Mazzaro C et al. Efficacy and safety of Rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-3834
14. Zaja F, Russo D, Fuga G, Patriarca F, Ermacora A, Baccarani M. Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 1999; 84: 1157-1158
15. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756
16. Rossi P, Bertani T, Baio P et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int 2003; 63: 2236-2241
17. Manns MP, McHutchison JG, Gordon SC et al. PEG interferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965
18. Lamprecht P, Moosig F, Gause A et al. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2001; 60: 385-390
19. Margin S, Craxi A, Fabiano C et al. Hepatitis C viraemia in chronic liver disease: relationship to interferon alpha or corticosteroid treatment. Hepatology 1994; 19: 273-279
20. Looney RJ. Treating human autoimmune disease by depleting B cells. Ann Rheum Dis 2002; 61: 863-866